Burning forefoot pain can limit every step your patient takes. Tight shoes become intolerable. Walking becomes frustrating. Exercise gets pushed aside. For many patients, the problem involves irritation and compression of the common plantar digital nerve: often called Morton’s neuroma.
Your clinic can address this condition with a structured, conservative protocol that combines clinical assessment, mechanical off-loading, movement-based care, and JointWave™ high-intensity shockwave therapy.
The goal is not to promise a universal cure. The goal is to identify appropriate candidates, apply evidence-informed care, track measurable outcomes, and give patients a non-invasive option before injections or surgery.
Better Assessment. Better Targeting. Better Outcomes.
Morton’s neuroma typically affects the third intermetatarsal space, although the second space can also become symptomatic. Despite its name, a Morton’s neuroma is not usually a tumor. It generally involves thickening and irritation around an interdigital nerve, often associated with repeated compression beneath the deep transverse metatarsal ligament.
Patients commonly describe:
- Burning or sharp forefoot pain
- Tingling or numbness into adjacent toes
- A “pebble in the shoe” sensation
- Symptoms that worsen in narrow or high-heeled footwear
- Pain that improves when shoes come off or the forefoot receives rest
Begin with a focused history and examination. Palpate the symptomatic web space, perform a forefoot squeeze, and assess for a painful Mulder-type click. Check gait, footwear, metatarsal loading, ankle mobility, and proximal kinetic-chain contributions.
Do not assume every case of forefoot pain represents Morton’s neuroma. Consider plantar plate injury, stress fracture, intermetatarsal bursitis, MTP arthritis, Freiberg disease, mechanical metatarsalgia, and other causes.
✅ Refer for ultrasound, MRI, or podiatric/orthopedic evaluation when findings remain unclear, symptoms appear atypical, neurological deficits progress, or the patient fails conservative care.
Deeper Biology. Calmer Nerves. Stronger Recovery.
JointWave delivers high-intensity acoustic energy into targeted soft tissue. That mechanical stimulus may create a biological response called mechanotransduction, in which cells respond to physical energy by changing local repair and signaling activity.
For Morton’s neuroma, proposed mechanisms include:
- Neuromodulation: Shockwave energy may reduce the sensitivity of pain-producing nerve endings and alter nociceptive signaling.
- Microcirculatory support: Acoustic energy may encourage local blood-flow changes and improve the tissue environment around irritated structures.
- Tissue remodeling: Mechanical stimulation may support remodeling of fibrotic and chronically stressed soft tissue.
- Inflammatory modulation: Shockwave therapy may influence inflammatory mediators involved in persistent pain.
These mechanisms help explain why pain can improve even when the neuroma itself does not immediately shrink on imaging. The clinical target is not simply the size of the nerve. It is the patient’s pain, function, loading tolerance, and ability to move.
However, keep the evidence in perspective. A randomized placebo-controlled trial published in the Journal of the American Podiatric Medical Association found that patients receiving ESWT experienced significant improvements in pain at one and four weeks, along with improved foot-function scores at four weeks. Ultrasound-measured neuroma diameter did not significantly change.[^1]
A second small randomized trial also reported short-term improvement compared with sham treatment. Yet the overall Morton’s neuroma literature remains limited, with small sample sizes, differing protocols, and short follow-up periods.[^2] Present JointWave as a promising conservative option, not as a guaranteed replacement for every injection or surgical procedure.
Screen Carefully. Treat Precisely. Track Everything.
A practical JointWave protocol should begin with patient selection and measurable baselines.
1. Confirm the clinical pattern
Document:
- Primary pain location and symptom distribution
- Pain intensity at rest and during walking
- Shoe and activity limitations
- Sensory changes in the involved toes
- Provocative examination findings
- Relevant imaging or outside diagnoses
Use a simple 0–10 pain scale and record at least one functional measure, such as walking tolerance, standing time, or the number of days the patient can exercise.
2. Reduce compression first
Shockwave therapy works best within a broader care plan. Address the mechanical environment contributing to nerve irritation.
Recommend appropriate measures within your scope, such as:
- ✅ Wider footwear with adequate toe-box space
- ✅ Reduced use of high heels or narrow shoes
- ✅ A metatarsal pad positioned proximal to the metatarsal heads
- ✅ Temporary modification of aggravating activities
- ✅ Foot, ankle, calf, and kinetic-chain mobility work
- ✅ Progressive intrinsic-foot and lower-extremity strengthening when tolerated
Avoid presenting JointWave as a stand-alone solution. Off-loading can reduce continued irritation while the patient progresses through care.
3. Target the symptomatic region
Use your clinical examination: and imaging when available: to identify the symptomatic intermetatarsal space. Position the patient comfortably and apply acoustic energy according to JointWave training, manufacturer guidance, patient tolerance, and applicable clinical regulations.
Published studies have used different energy levels, shock counts, anesthesia decisions, and session schedules. That variation matters. Do not copy a research protocol directly onto a different device or patient population without appropriate training.
Many clinicians prefer to avoid local anesthesia when clinically appropriate because anesthesia may alter the mechanotransduction response. Patient comfort and treatment completion still matter, so make individualized decisions based on tolerance, contraindications, and professional judgment.
4. Reassess between visits
Track pain and function at each visit. Ask:
- Can the patient tolerate shoes longer?
- Has walking distance improved?
- Has toe tingling decreased?
- Does the forefoot squeeze reproduce less pain?
- Has the patient resumed a valued activity?
If symptoms worsen, neurological findings progress, or the clinical picture changes, stop and reassess the diagnosis.
Combine Modalities. Improve Compliance. Expand Care.
Your chiropractic practice already understands the value of treating the whole movement system. Morton’s neuroma care can fit naturally into that model.
JointWave may complement:
- Foot and ankle mobilization
- Soft-tissue work around the calf and plantar structures
- Gait and loading assessment
- Lower-extremity mobility programming
- Metatarsal off-loading strategies
- Progressive strengthening
- Chiropractic care for related kinetic-chain dysfunction
Use shockwave therapy as one part of an organized plan. Begin with patient education, establish realistic expectations, and explain that tissue recovery may continue after the treatment visit.
A clear care plan improves compliance because the patient understands what to do between sessions. It also gives your team a consistent workflow for screening, education, treatment, and follow-up.
Superior Hardware. Lower Downtime. Better ROI.
Not every shockwave system offers the same clinical or operational experience. JointWave’s high-intensity system gives your practice access to powerful acoustic energy designed to reach deeper soft-tissue structures than superficial pressure-based modalities.
JointWave treatment heads are technologically superior and built to outlast major competitors, supporting consistent energy delivery and a stronger long-term return on investment. Durable treatment heads matter because downtime, inconsistent output, and frequent replacement can quickly reduce the value of any equipment purchase.
The JointWave advantage includes:
- ✅ High-intensity acoustic energy for targeted soft-tissue care
- ✅ Treatment heads built for demanding clinical use
- ✅ Consistent delivery across a high-volume schedule
- ✅ Staff training and white-glove installation
- ✅ Marketing materials to help introduce the service
- ✅ A workflow that can complement existing chiropractic care
More Options. More Value. More Revenue.
Morton’s neuroma patients often seek solutions after footwear changes, rest, and basic conservative measures have failed. That creates an opportunity for your clinic to offer a structured, private-pay service centered on assessment, education, and measurable progress.
A cash-based service can help your practice:
- ✅ Reduce dependence on insurance reimbursement
- ✅ Add a specialized treatment option without drugs or injections
- ✅ Increase the value of existing patient relationships
- ✅ Create clearly defined care packages
- ✅ Generate referrals from patients seeking non-surgical options
For example, a clinic might create a four-visit forefoot pain program priced at $700. Eight new patients completing that program would generate $5,600 in gross revenue. This is an illustrative example: not a recommended fee: and your pricing should reflect your market, training, costs, compliance requirements, and patient value.
Build revenue around outcomes and service quality, not exaggerated promises. Explain what the patient receives, how progress gets measured, and when referral or additional evaluation becomes appropriate.
Install. Train. Launch With Confidence.
Adding new technology should not require your team to figure everything out alone. JointWave supports implementation with:
- Installation: A representative helps set up the system in your office.
- Training: Your team learns appropriate operation, positioning, and workflow.
- Marketing support: Use provided materials to educate current and prospective patients.
- Practice integration: Add the service to consultations, care plans, and follow-up systems.
- Outcome tracking: Measure pain, function, and patient satisfaction.
Try JointWave Risk-Free. Decide With Confidence.
You do not need to make a long-term decision based on a brochure or demonstration alone. JointWave offers a 30-day risk-free, in-office trial with no obligation.
Bring the system into your clinic. Train your staff. Identify appropriate patients. Test your workflow. Track outcomes. Evaluate the financial opportunity with your own team and patient population.
Visit jointwavetrial.com today to start your 30-day risk-free trial.
References
[^1]: Seok H, Kim SH, Lee SY, Park SW. “Extracorporeal shockwave therapy in patients with Morton’s neuroma: a randomized, placebo-controlled trial.” Journal of the American Podiatric Medical Association. 2016;106(2):93–99. PubMed
[^2]: Thomson L, Aujla RS, Divall P, Bhatia M. “Non-surgical treatments for Morton’s neuroma: a systematic review.” Foot and Ankle Surgery. 2020;26(7):736–743. PubMed
Further reading: How to Integrate Chiropractic Shockwave Therapy With Spinal Adjustments and The ROI of High-Intensity Shockwave Therapy for Chiropractic Clinics.